Literature DB >> 25671270

High-cost generic drugs--implications for patients and policymakers.

Kathleen Uhl, John R Peters, Keith Flanagan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25671270     DOI: 10.1056/NEJMc1415471

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  ACMT Position Statement: Addressing the Rising Cost of Prescription Antidotes.

Authors:  Maryann Mazer-Amirshahi; Andrew Stolbach; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2017-11-28

2.  Correction to: ACMT Position Statement: Addressing the Rising Cost of Prescription Antidotes.

Authors:  Maryann Mazer-Amirshahi; Andrew Stolbach; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2018-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.